JPWO2021228052A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021228052A5 JPWO2021228052A5 JP2022568638A JP2022568638A JPWO2021228052A5 JP WO2021228052 A5 JPWO2021228052 A5 JP WO2021228052A5 JP 2022568638 A JP2022568638 A JP 2022568638A JP 2022568638 A JP2022568638 A JP 2022568638A JP WO2021228052 A5 JPWO2021228052 A5 JP WO2021228052A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- fusion protein
- igg
- seq
- protein according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025209848A JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010393721.9 | 2020-05-11 | ||
| CN202010393721.9A CN113637084B (zh) | 2020-05-11 | 2020-05-11 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
| PCT/CN2021/092861 WO2021228052A1 (zh) | 2020-05-11 | 2021-05-10 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025209848A Division JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023526218A JP2023526218A (ja) | 2023-06-21 |
| JP2023526218A5 JP2023526218A5 (https=) | 2025-06-17 |
| JPWO2021228052A5 true JPWO2021228052A5 (https=) | 2025-06-17 |
| JP7834347B2 JP7834347B2 (ja) | 2026-03-24 |
Family
ID=78415417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Active JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
| JP2025209848A Pending JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025209848A Pending JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230348554A1 (https=) |
| EP (1) | EP4151659A4 (https=) |
| JP (2) | JP7834347B2 (https=) |
| CN (2) | CN113637084B (https=) |
| CA (1) | CA3178088A1 (https=) |
| WO (1) | WO2021228052A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114920849A (zh) * | 2022-03-09 | 2022-08-19 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种靶向补体免疫抑制蛋白及其构建方法及应用 |
| WO2025103318A1 (zh) * | 2023-11-13 | 2025-05-22 | 沈阳三生制药有限责任公司 | 一种靶向C3b的双功能融合蛋白及其制备方法与用途 |
| CN121159642B (zh) * | 2025-11-20 | 2026-04-03 | 山东第二医科大学 | 补体c9迷你结合蛋白或其突变体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| EP3524620A1 (en) * | 2008-10-14 | 2019-08-14 | Genentech, Inc. | Immunoglobulin variants and uses thereof |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
| WO2019075519A1 (en) * | 2017-10-18 | 2019-04-25 | Csl Limited | HUMAN SERUM ALBUMIN VARIANTS AND USES THEREOF |
| SI3793586T1 (sl) * | 2018-05-16 | 2024-07-31 | Csl Limited | Različice receptorja za topni komplement tipa 1 in njihova uporaba |
| WO2020041644A1 (en) * | 2018-08-22 | 2020-02-27 | Alexion Pharmaceuticals, Inc. | Fusion proteins and methods of treating complement dysregulation using the same |
| CN111018999B (zh) * | 2019-12-05 | 2022-07-12 | 沣潮医药科技（上海）有限公司 | 二聚体免疫融合蛋白、药物组合物和用途 |
-
2020
- 2020-05-11 CN CN202010393721.9A patent/CN113637084B/zh active Active
-
2021
- 2021-05-10 JP JP2022568638A patent/JP7834347B2/ja active Active
- 2021-05-10 WO PCT/CN2021/092861 patent/WO2021228052A1/zh not_active Ceased
- 2021-05-10 CA CA3178088A patent/CA3178088A1/en active Pending
- 2021-05-10 EP EP21804660.5A patent/EP4151659A4/en active Pending
- 2021-05-10 CN CN202180034009.2A patent/CN115515985A/zh active Pending
- 2021-05-10 US US17/998,367 patent/US20230348554A1/en active Pending
-
2025
- 2025-11-28 JP JP2025209848A patent/JP2026035742A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109641034B (zh) | 聚乙二醇化的猪干扰素及其使用方法 | |
| KR950014915B1 (ko) | 탈시알로당단백-포함화합물 | |
| EP2593084B1 (en) | A liquid formulation of long-acting human growth hormone conjugate | |
| KR101712245B1 (ko) | TNFR 및 면역글로블린 Fc 영역을 포함하는 융합 단백질을 포함하는 액상 제제 | |
| JP6047495B2 (ja) | 持続型インターフェロンアルファ結合体の液状製剤 | |
| RS55428B1 (sr) | Liofilizovane formulacije terapeutskih peptitela | |
| JPH03504967A (ja) | 血液脳関門を介しての神経ペプチド運搬のためのキメラ性ペプチド | |
| JP6549104B2 (ja) | 持続型ヒト成長ホルモン製剤 | |
| JP2008500373A5 (https=) | ||
| JP2023539476A (ja) | アネキシンａ１のｎ末端ペプチド製剤及び方法 | |
| JP2018115166A (ja) | 持続型ヒト成長ホルモン結合体の高濃度液剤 | |
| JP2001500876A (ja) | 液体形態の改良された安定性を有するコルチコトロピン放出因子の医薬製剤 | |
| US11510966B2 (en) | Use of IL-22 in treating necrotizing enterocolitis | |
| Pontzer et al. | Structure/function studies with interferon tau: evidence for multiple active sites | |
| JP3544180B2 (ja) | 安定化した顆粒球コロニー刺激因子 | |
| JPWO2021228052A5 (https=) | ||
| JPWO2020206320A5 (https=) | ||
| TW201735940A (zh) | 長效人類生長激素共軛物之新穎液體調配物 | |
| US20030148265A1 (en) | Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein | |
| CN115666522B (zh) | 包含il-2蛋白和cd80蛋白的融合蛋白制剂 | |
| JP2025509059A (ja) | α－ガラクトシダーゼＡの融合タンパク質を含む凍結乾燥製剤 | |
| KR102844063B1 (ko) | 혼성 fc 융합된 g-csf를 위한 안정한 동결 건조 제형 | |
| JP4240165B2 (ja) | 血小板由来白血球貪食能亢進因子の活性化因子 | |
| CN110563832A (zh) | 一种高纯度重组促卵泡刺激素纯化方法 | |
| WO2004096843A1 (ja) | 消化器官吸収性ポリペプチド |